{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:18:12Z","timestamp":1774880292667,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010763","name":"Zorginstituut Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ahj.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:44:42Z","timestamp":1651920282000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["COMPARE LAAO: Rationale and design of the randomized controlled trial \u201cCOMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy\u201d"],"prefix":"10.1016","volume":"250","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-3156","authenticated-orcid":false,"given":"Marina","family":"Huijboom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moniek","family":"Maarse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Errol","family":"Aarnink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Swaans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sander","family":"IJsselmuiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Folkeringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Elvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Stevenhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Vlachojannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepijn","family":"van der Voort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"Westra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisevi","family":"Chaldoupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muchtiar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"van der Kley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"van Mieghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewoud","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2022.05.001_bib0001","unstructured":"de Boer AR, van Dis I, Vaartjes I, Bots ML, Kerncijfers over hart- en vaatziekten. In: de Boer AR, van Dis I, Visseren FLJ, Vaartjes I, Bots ML. Hart- en vaatziekten in Nederland 2019, cijfers over incidentie, prevalentie, ziekte en sterfte. Den Haag: Hartstichting, 2019."},{"key":"10.1016\/j.ahj.2022.05.001_bib0002","first-page":"1","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS)","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahj.2022.05.001_bib0003","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Int Med"},{"key":"10.1016\/j.ahj.2022.05.001_bib0004","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2022.05.001_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus Warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2022.05.001_bib0006","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus Warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2022.05.001_bib0007","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus Warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2022.05.001_bib0008","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2022.05.001_bib0009","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2022.05.001_bib0010","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2022.05.001_bib0011","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart R","volume":"74","author":"January","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2022.05.001_bib0012","doi-asserted-by":"crossref","first-page":"e21209","DOI":"10.1097\/MD.0000000000021209","article-title":"Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience","volume":"99","author":"Gorczyca","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ahj.2022.05.001_bib0013","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/1755-5922.12129","article-title":"Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation","volume":"33","author":"Steinberg","year":"2015","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ahj.2022.05.001_bib0014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ahj.2014.07.002","article-title":"Reasons for warfarin discontinuation in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"168","author":"O\u2019Brien","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ahj.2022.05.001_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/03007995.2020.1725743","article-title":"Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation","volume":"36","author":"Mitrovic","year":"2020","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ahj.2022.05.001_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21357","article-title":"Latent classes of adherence to oral anticoagulation therapy among patients with a new diagnosis of atrial fibrillation","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw. open"},{"key":"10.1016\/j.ahj.2022.05.001_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2019-034778","article-title":"Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"10","author":"Salmasi","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ahj.2022.05.001_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"10.1016\/j.ahj.2022.05.001_bib0019","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahj.2022.05.001_bib0020","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahj.2022.05.001_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2017.03.007","article-title":"The assessment of the watchman device in patients unsuitable for oral anticoagulation (ASAP-TOO) trial","volume":"189","author":"Holmes","year":"2017","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ahj.2022.05.001_bib0022","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2022.05.001_bib0023","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.amjcard.2016.08.075","article-title":"Characterization of cerebrovascular events after left atrial appendage occlusion","volume":"118","author":"Freixa","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahj.2022.05.001_bib0024","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials - A literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2022.05.001_bib0025","doi-asserted-by":"crossref","unstructured":".Lakireddy D, Thaler D, Ellis CR, et\u00a0al., Amplatzer amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized controlled trial. Circulation. 2021 Nov 9;144(19):1543-1552.","DOI":"10.1161\/CIRCULATIONAHA.121.057063"},{"key":"10.1016\/j.ahj.2022.05.001_bib0026","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.05.001_bib0027","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion","volume":"13","author":"Korsholm","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ahj.2022.05.001_bib0028","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish atrial fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahj.2022.05.001_bib0029","unstructured":"NHS England. Clinical commissioning policy: left atrial appendage occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (adults). 1\u201328 (2018)."},{"key":"10.1016\/j.ahj.2022.05.001_bib0030","unstructured":"Centers for Medicare & Medicaid Services. Final decision memorandum for percutaneous left atrial appendage closure (LAAC). (2016)."},{"key":"10.1016\/j.ahj.2022.05.001_bib0031","first-page":"1","article-title":"Public summary document - left atrial appendage closure for stroke prevention in patients with non-valvular atrial fibrillation","year":"2013","journal-title":"Public ARTG Summ"},{"key":"10.1016\/j.ahj.2022.05.001_bib0032","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/STROKEAHA.119.025626","article-title":"Diagnostic accuracy of the explicit diagnostic criteria for transient ischemic attack: a validation study","volume":"50","author":"Dolmans","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2022.05.001_bib0033","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMcp1908837","article-title":"Transient ischemic attack","author":"Amarenco","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahj.2022.05.001_bib0034","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/STROKEAHA.109.577650","article-title":"Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists","volume":"41","author":"Castle","year":"2010","journal-title":"Stroke"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:08:51Z","timestamp":1757570931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870322000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"alternative-id":["S0002870322000850"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2022.05.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COMPARE LAAO: Rationale and design of the randomized controlled trial \u201cCOMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy\u201d","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}